Under-expression of α8 integrin aggravates experimental atherosclerosis

Area of Science:

• Vascular Biology
• Integrin Signaling
• Atherosclerosis Research

Background:

• Integrins are crucial in vascular biology.
• The role of alpha-8 integrin (α8) in atherosclerosis is not well understood.
• α8 is known to inhibit smooth muscle cell migration.

Purpose of the Study:

• To investigate the role of α8 integrin in atherosclerosis and vascular remodeling.
• To test the hypothesis that reduced α8 expression exacerbates atherosclerosis.
• To determine the consequences of α8 deficiency in vascular disease models.

Main Methods:

• Immunohistochemistry and qPCR to detect α8 integrin expression.
• α8 integrin-deficient mice (α8(-/-), α8(+/-)) and wild-type littermates (α8(+/+)) were used.
• Two models of atherosclerotic lesions were induced: carotid artery ligation and ApoE-deficient background.

Main Results:

• α8 integrin was down-regulated in human and murine atherosclerotic arteries.
• α8 deficiency (α8(-/-) and α8(+/-)) aggravated medial thickening and neointima formation after carotid ligation.
• ApoE-deficient mice lacking α8 developed more severe atherosclerotic plaques.
• Complete α8 loss caused renal damage, including reduced renal mass and glomerulosclerosis.

Conclusions:

• α8 integrin plays a protective role in arterial remodeling and atherosclerosis.
• Under-expression of α8 aggravates vascular lesions.
• Complete loss of α8 leads to renal complications in the context of atherosclerosis.